Josefin Skogsberg

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. ncbi ApoB100-LDL acts as a metabolic signal from liver to peripheral fat causing inhibition of lipolysis in adipocytes
    Josefin Skogsberg
    The Computational Medicine Group, Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden
    PLoS ONE 3:e3771. 2008
  2. ncbi Transcriptional profiling uncovers a network of cholesterol-responsive atherosclerosis target genes
    Josefin Skogsberg
    The Computational Medicine Group, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden
    PLoS Genet 4:e1000036. 2008
  3. ncbi Multi-organ expression profiling uncovers a gene module in coronary artery disease involving transendothelial migration of leukocytes and LIM domain binding 2: the Stockholm Atherosclerosis Gene Expression (STAGE) study
    Sara Hägg
    The Computational Medicine Group, Atherosclerosis Research Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    PLoS Genet 5:e1000754. 2009
  4. ncbi Blood levels of dual-specificity phosphatase-1 independently predict risk for post-operative morbidities causing prolonged hospitalization after coronary artery bypass grafting
    Sara Hägg
    The Cardiovascular Genomics Group, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Stockholm, Sweden
    Int J Mol Med 27:851-7. 2011
  5. ncbi Carotid plaque age is a feature of plaque stability inversely related to levels of plasma insulin
    Sara Hägg
    The Cardiovascular Genomics Group, Department of Medical Biochemistry and Biophysics, Solna, Karolinska Institutet, Stockholm, Sweden
    PLoS ONE 6:e18248. 2011
  6. ncbi PPARdelta increases expression of the human apolipoprotein A-II gene in human liver cells
    Petra Thulin
    Atherosclerosis Research Unit, Department of Medicine, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, SE 171 76 Stockholm, Sweden
    Int J Mol Med 21:819-24. 2008
  7. ncbi MMP-2 and MMP-9 are prominent matrix metalloproteinases during atherosclerosis development in the Ldlr(-/-)Apob(100/100) mouse
    Dick Wågsäter
    Atherosclerosis Research Unit, Center for Molecular Medicine, Department of Medicine, Karolinska Institute, Solna, Stockholm, Sweden
    Int J Mol Med 28:247-53. 2011
  8. ncbi Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor delta
    David Kitz Krämer
    Department of Surgical Science, Karolinska Institute, Stockholm, Sweden
    Diabetes 54:1157-63. 2005
  9. ncbi The low density lipoprotein receptor prevents secretion of dense apoB100-containing lipoproteins from the liver
    Sofia L Larsson
    Atherosclerosis Research Unit, King Gustaf V Research Institute, Karolinska Institutet, Karolinska Hospital, 17176 Stockholm, Sweden
    J Biol Chem 279:831-6. 2004
  10. ncbi Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Multi-organ whole-genome measurements and reverse engineering to uncover gene networks underlying complex traits
    Jesper Tegner
    The CoCenter for Molecular Medicine, King Gustaf V Research Institute, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Solna, SE 171 76 Stockholm, Sweden
    J Lipid Res 48:267-77. 2007

Collaborators

Detail Information

Publications12

  1. ncbi ApoB100-LDL acts as a metabolic signal from liver to peripheral fat causing inhibition of lipolysis in adipocytes
    Josefin Skogsberg
    The Computational Medicine Group, Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden
    PLoS ONE 3:e3771. 2008
    ..Whether there also exists a reciprocal metabolic arm affecting energy metabolism in white adipose tissue is unknown...
  2. ncbi Transcriptional profiling uncovers a network of cholesterol-responsive atherosclerosis target genes
    Josefin Skogsberg
    The Computational Medicine Group, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden
    PLoS Genet 4:e1000036. 2008
    ..This network should be of interest for the development of novel atherosclerosis therapies...
  3. ncbi Multi-organ expression profiling uncovers a gene module in coronary artery disease involving transendothelial migration of leukocytes and LIM domain binding 2: the Stockholm Atherosclerosis Gene Expression (STAGE) study
    Sara Hägg
    The Computational Medicine Group, Atherosclerosis Research Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    PLoS Genet 5:e1000754. 2009
    ..Thus, the A-module appears to be important for atherosclerosis development and, together with LDB2, merits further attention in CAD research...
  4. ncbi Blood levels of dual-specificity phosphatase-1 independently predict risk for post-operative morbidities causing prolonged hospitalization after coronary artery bypass grafting
    Sara Hägg
    The Cardiovascular Genomics Group, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Solna, Stockholm, Sweden
    Int J Mol Med 27:851-7. 2011
    ....
  5. ncbi Carotid plaque age is a feature of plaque stability inversely related to levels of plasma insulin
    Sara Hägg
    The Cardiovascular Genomics Group, Department of Medical Biochemistry and Biophysics, Solna, Karolinska Institutet, Stockholm, Sweden
    PLoS ONE 6:e18248. 2011
    ..We took advantage of the atmospheric (14)C-declination curve (a result of the atomic bomb tests in the 1950s and 1960s) to determine the average biological age of carotid plaques...
  6. ncbi PPARdelta increases expression of the human apolipoprotein A-II gene in human liver cells
    Petra Thulin
    Atherosclerosis Research Unit, Department of Medicine, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, SE 171 76 Stockholm, Sweden
    Int J Mol Med 21:819-24. 2008
    ..In conclusion, PPARdelta increases the expression of the human apoA-II gene in liver cells via a PPRE in the proximal promoter...
  7. ncbi MMP-2 and MMP-9 are prominent matrix metalloproteinases during atherosclerosis development in the Ldlr(-/-)Apob(100/100) mouse
    Dick Wågsäter
    Atherosclerosis Research Unit, Center for Molecular Medicine, Department of Medicine, Karolinska Institute, Solna, Stockholm, Sweden
    Int J Mol Med 28:247-53. 2011
    ..The study suggests that MMP-2 and MMP-9 are the main proteases involved in atherogenesis in this mouse model...
  8. ncbi Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferator-activated receptor delta
    David Kitz Krämer
    Department of Surgical Science, Karolinska Institute, Stockholm, Sweden
    Diabetes 54:1157-63. 2005
    ..Moreover, we provide biological validation of PPARdelta as a potential target for antidiabetic therapy...
  9. ncbi The low density lipoprotein receptor prevents secretion of dense apoB100-containing lipoproteins from the liver
    Sofia L Larsson
    Atherosclerosis Research Unit, King Gustaf V Research Institute, Karolinska Institutet, Karolinska Hospital, 17176 Stockholm, Sweden
    J Biol Chem 279:831-6. 2004
    ..In addition, these results suggest that very low levels of MTP are insufficient to mediate the second step but sufficient for the first step of VLDL assembly...
  10. ncbi Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Multi-organ whole-genome measurements and reverse engineering to uncover gene networks underlying complex traits
    Jesper Tegner
    The CoCenter for Molecular Medicine, King Gustaf V Research Institute, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Solna, SE 171 76 Stockholm, Sweden
    J Lipid Res 48:267-77. 2007
    ..We also address how gene networks will probably play a key role in the development of early diagnostics and treatments for complex disorders in the coming era of individualized medicine...
  11. ncbi PPARdelta activation induces COX-2 gene expression and cell proliferation in human hepatocellular carcinoma cells
    Bjorn Glinghammar
    King Gustaf V Research Institute, Karolinska Institutet, Karolinska Hospital, S 171 76 Stockholm, Sweden
    Biochem Biophys Res Commun 308:361-8. 2003
    ..These results may suggest that PPARdelta plays an important role in the development of HCC by modulating expression of COX-2...
  12. ncbi Troglitazone stimulates IGF-binding protein-1 by a PPAR gamma-independent mechanism
    Agneta Hilding
    Department of Molecular Medicine, Karolinska Institutet and Hospital, Stockholm, Sweden
    Biochem Biophys Res Commun 303:693-9. 2003
    ..We conclude that the effect of troglitazone on IGFBP-1 production by HepG2 cells is independent of PPAR and may involve PXR...